Today on DrugResearcher.com   Merck HIV vaccine failure puts cold virus on trial Aveo strategy ups chances of cancer drug success The sweet taste of analysing biological drugs 'World's first' NanoImaging service centre opens Drugs moving into the clinic: 34

Related Industry News   West unscathed by Exubera shot - for now Good news follows bad news for InVentiv Add PEG to make the drug go farther P&G in shock nasal spray exit

Breaking News on Drug Discovery
Daily  Thursday 08 November 2007		Forward to a colleague

	Technical / White Paper Manufacturing Variations in Polysorbate Batches Lot to lot variances in a series of Polysorbate preparations was easily and clearly differentiated and identified by utilizing charged aerosol detection (CAD), a new universal detectorfor HPLC... Click Here Access Full Stories Merck HIV vaccine failure puts cold virus on trial Merck & Co's failed HIV vaccine may actually increase the risk of infection and the latest data raises questions over whether the cold virus used as a delivery technique was at fault... Read Aveo strategy ups chances of cancer drug success US-based Aveo Biopharmaceuticals is hoping to prove its R&D strategy can buck high industry failure rates when trying to design new cancer drugs and it seems to be working after its lead drug has passed a first-in-man... Read The sweet taste of analysing biological drugs Researchers from Amgen have published results detailing a method that improves the analysis of the sugar groups attached to monoclonal antibodies (MAbs) and proteins... Read 'World's first' NanoImaging service centre opens NanoImaging Services has opened what it claims is a first of its kind first fee-for-service imaging business to enable structural characterisation and validation of biological drugs throughout the development... Read Drugs moving into the clinic: 34 The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators... Read
	All News Headlines for: November | October | September
	Product Brochure Innovative New Shaking Incubator from Stuart® A compact bench top incubator can be just enough for bacterial cell culturing. The latest shaking incubator from Stuart® is packed with novel features such as BioCote antimicrobial protection:... Click Here
	Related Industry News West unscathed by Exubera shot - for now West Pharmaceutical Services, one of the two firms responsible for manufacturing Pfizer's failed Exubera device, recently turned in its third quarter financials, so far avoiding any major dent from the company's... Read Good news follows bad news for InVentiv After losing a key Novartis contract and getting caught up in the Inyx collapse, Inventiv Health had good news this week when it reported its third quarter results... Read Add PEG to make the drug go farther A US research team has found a way to increase drug distribution in the brain to fight the recurrence of human brain tumours... Read P&G in shock nasal spray exit Procter & Gamble (P&G) has this week terminated an agreement with Nastech to develop a nasally delivered version of Eli Lilly's osteoporosis drug Forteo (teriparatide), leaving its partner with no explanation... Read Weekly Comment Big pharma lends a helping hand Despite often attracting a barrage of negative publicity, particularly in regard to a perception of putting profits before people, big pharma firms are still capable of showing their human side in times of crisis. Read Product Presentation Rapid HPLC method development with ChromSword®Auto software Avoid the tedious search for good HPLC methods for separation with ChromSword®Auto's quicker chromatography solutions... Click Here Previous Headlines AstraZeneca CEO hacks at pipeline to up profits AstraZeneca's CEO has said the company will stop research in a number of diseases as it continues to cut costs and restructure in the face of falling sales... Read Sanofi pushes on with cell culture flu shot Sanofi Pasteur has kicked off Phase II trials of its cell culture-based seasonal flu vaccine in the US, part of a five year project with the US Department of Health and Human Services (HHS)... Read Merck flexes muscle with GTx deal Merck & Co has inked a deal potentially worth over €507m (€346m) with GTx over a new class of drugs to treat muscle loss conditions, especially those caused by cancer... Read Biomarker market predicted to 'explode' The global market for biomarkers is expected to more than double over the next 5 years to reach an estimated $12.8bn (€8.7bn), according to a new market research report... Read Preclinical services news in brief In this week's review of activity within the preclinical research services arena, new deals have emerged involving MDS Pharma Services, Bruker Biospin and Expression Analysis... Read Technical / White Papers, Case studies, Web casts Benefits of integrating human tissue research in drug discovery - Technical / White Paper Manufacturing Variations in Polysorbate Batches - Technical / White Paper Product Information - brochures, Web centers ZIC®-HILIC Separation of Polar and Hydrophilic Compounds - Product Presentation DAICEL chiral chromatography products - Company Profile Rapid HPLC method development with ChromSword®Auto software - Product Presentation Separation of polar compounds - Application Notes Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analysis and instrumentation Assays and screening Cell culture & Equipment Chromatography Compounds and consumables Contract services (outsourcing) Drug discovery Genomics / Proteomics Informatics & IT Lab equipment & consumables Liquid handling and automation Liquid handling and sample preparation Production technologies Separation and purification

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com